---
$id: https://graph.org.ai/products/commodity/51142526
$type: Product
source: UNSPSC
code: "51142526"
title: "Ethopropazine or profenamine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ethopropazine or profenamine

**UNSPSC Code**: 51142526
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C19H24N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7WI4P02YN1, chemically known as 10h-phenothiazine-10-ethanamine, n,n-diethyl-.alpha.-methyl-, monohydrochloride but generally known as ethopropazine, which bears US NIH Compound Identifier 3290. European Medicines Agency schedules Profenamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10071MIG. The term ETHOPROPAZINE is an International Non-Proprietary Name. World Health Organization schedules ethopropazine in its Anatomical Therapeutic Chemical (ATC) Classification. Ethopropazine or profenamine bears US NLM identifiers UMLS ID C0015042 and NCI Concept Code C73333. SMILES: CCN(CC)C(C)CN1C2=CC=CC=C2SC3=CC=CC=C31.

